This compound is a fluorinated, iodinated pyrimidinedione derivative used as a pharmaceutical intermediate. Its structure features a pyrimidine ring with iodine and methyl substituents, linked to a difluorinated benzyl group bearing a trifluoromethyl moiety.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1150560-54-5
5-bromo-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
pharmaceutical intermediate
5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1h,3h)-pyrimidinedione
pharmaceutical intermediate
2-[2-[[(Phenylmethoxy)carbonyl]amino]-4-thiazolyl]-2-pentenedioic acid 5-(3-methyl-2-butenyl) ester
pharmaceutical intermediate
Ethyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate
pharmaceutical intermediate
5-Bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine
pharmaceutical intermediate
1-{[2-Fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methylpyrimidine-2,4(1H,3H)-dione
pharmaceutical intermediate
Alogliptin impurity
research compound
2-((6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)methyl)benzonitrile
research compound
1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-5-iodo-6-methylpyrimidine-2,4-dione
TZBUKGISILNJCR-UHFFFAOYSA-N
CC1=C(C(=O)NC(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)I
—